| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 17.959 | 18.811 | 27.068 | 27.549 | 22.088 | 29.911 | 25.403 | 10.587 | 4.661 |
| Total Income - EUR | - | 17.959 | 18.811 | 27.068 | 27.549 | 22.088 | 29.911 | 25.403 | 10.587 | 4.661 |
| Total Expenses - EUR | - | 8.759 | 7.164 | 7.611 | 6.933 | 6.650 | 6.668 | 5.387 | 4.383 | 4.715 |
| Gross Profit/Loss - EUR | - | 9.199 | 11.647 | 19.457 | 20.616 | 15.438 | 23.244 | 20.016 | 6.204 | -54 |
| Net Profit/Loss - EUR | - | 9.020 | 11.459 | 19.187 | 20.341 | 15.217 | 22.945 | 19.767 | 5.349 | -54 |
| Employees | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Suf - Euromed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 645 | 445 | 246 |
| Current Assets | - | 9.648 | 12.104 | 19.636 | 20.978 | 18.092 | 23.569 | 25.216 | 6.197 | 6.136 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 333 | 685 | 1.131 | 14.071 | 10.337 | 15.191 | 21.226 | 936 | 554 |
| Cash | - | 9.315 | 11.419 | 18.506 | 6.908 | 7.756 | 8.378 | 3.990 | 5.261 | 5.582 |
| Shareholders Funds | - | 9.064 | 11.512 | 19.238 | 20.391 | 15.266 | 22.993 | 19.816 | 6.101 | 6.014 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 583 | 592 | 398 | 587 | 2.826 | 576 | 6.045 | 540 | 368 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Suf - Euromed Srl